Przemyslaw M Mrozikiewicz
Overview
Explore the profile of Przemyslaw M Mrozikiewicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
292
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rubis B, Holysz H, Barczak W, Gryczka R, Lacinski M, Jagielski P, et al.
Pharmacol Rep
. 2013 Feb;
64(6):1560-6.
PMID: 23406767
Background: The accumulation of mutagenic substances in the human body may result in DNA metabolism disruption followed by carcinogenesis. As a consequence of mutations in the genes coding for transmembrane...
12.
Zawilska K, Bala M, Bledowski P, Chmielewski D, Dobrowolski Z, Fraczek M, et al.
Pol Arch Med Wewn
. 2013 Feb;
122 Suppl 2:3-74.
PMID: 23385605
The overall objective of the Polish guidelines for the prevention and treatment of venous thromboembolism is to increase patient benefit and safety by appropriate prevention and treatment of deep vein...
13.
Mrozikiewicz P, Grzeskowiak E, Seremak-Mrozikiewicz A, Bogacz A, Barlik M, Semczuk A, et al.
Ginekol Pol
. 2012 Mar;
82(12):925-32.
PMID: 22384629
Human cytochrome P450 1A 1 is one of the most important enzymes participating in human carcinogenesis because it metabolites several procarcinogens to active carcinogenic metabolites. Additionally enzymes of CYP450 family...
14.
Boc-Zalewska A, Seremak-Mrozikiewicz A, Barlik M, Anna B, Mrozikiewicz P, Grzeskowiak E, et al.
Ginekol Pol
. 2011 Oct;
82(8):585-91.
PMID: 21957602
Introduction: Adrenomedullin (ADM) is indicated to be a biologically active polypeptide released by endothelium with strong hypotensive, long-acting vasodilatator properties. It is suggested that development of preeclampsia is partly related...
15.
Szkutnik-Fiedler D, Jedrzejczyk M, Grzeskowiak E, Bartkowiak-Wieczorek J, Seremak-Mrozikiewicz A, Drews K, et al.
Ginekol Pol
. 2011 Mar;
81(12):929-34.
PMID: 21395085
Side effects and contraindications connected with hormonal replacement therapy in climacterium resulted in search for new methods of softening menopausal symptoms. The aim of the following study was to evaluate,...
16.
Majchrzycki M, Mrozikiewicz P, Kocur P, Bartkowiak-Wieczorek J, Hoffmann M, Stryla W, et al.
Ginekol Pol
. 2011 Mar;
81(11):851-5.
PMID: 21365902
Pain of lumbosacral segment of the vertebral column and the pelvis concerns about 45% of all pregnant women. The change of the body posture during pregnancy is the result of...
17.
Bogacz A, Mrozikiewicz P, Bartkowiak-Wieczorek J, Czerny B, Karasiewicz M, Kujawski R, et al.
Ginekol Pol
. 2011 Mar;
81(11):814-20.
PMID: 21365896
Objective: Soybean phytoestrogens, such as genistein and daidzein, have become a popular alternative for women undergoing the treatment of menopause symptoms. These isoflavones are also commonly used in traditional medicine...
18.
Seremak-Mrozikiewicz A, Drews K, Kurzawinska G, Bogacz A, Grzeskowiak E, Mrozikiewicz P
Neuro Endocrinol Lett
. 2010 Dec;
31(5):717-23.
PMID: 21173738
Background: Recurrent miscarriages (RM) are significant social and clinical problem. One of suggested reason of RM is hyperhomocysteinemia. Polymorphic genes involved in homocysteine and folate metabolism, including 5,10-methylenetetrahydrofolate reductase (MTHFR)...
19.
Kujawski R, Mrozikiewicz P, Bogacz A, Cichocka J, Mikolajczak P, Czerny B, et al.
Ginekol Pol
. 2010 Sep;
81(8):600-5.
PMID: 20873122
Objective: Evaluation of the influence of the standardized extract from the herb of Epilobium angustifolium on ERalpha and ERbeta mRNA expression in rat ventral prostate tissue and free serum estradiol...
20.
Mrozikiewicz P, Bogacz A, Czerny B, Karasiewicz M, Kujawski R, Mikolajczak P, et al.
Ginekol Pol
. 2010 Sep;
81(7):516-20.
PMID: 20825053
Objective: Soybean isoflavones are phytoestrogens that reduce menopausal symptoms and decrease the risk of certain chronic diseases, such as cancer and cardiovascular diseases. Despite the widespread use of soybean isoflavones...